Try our beta test site

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

This study has been completed.
Information provided by (Responsible Party):
Eisai Inc. Identifier:
First received: February 19, 2008
Last updated: February 23, 2017
Last verified: February 2017
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 21, 2013
Publications automatically indexed to this study by Identifier (NCT Number):